Back to Screener

Envista Holdings Corporation Common Stock (NVST)

NYSE Mid Cap

Healthcare › Dental Equipment & Supplies

$23.43
Market Cap: $3.8B
Data as of Apr 3, 2026 (TTM)

Price History

Feb 9, 2026 — May 24, 2026

Investment Snapshot

  • Trading 99% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 9/9 — financially strong with improving fundamentals
  • ROE of 1.7% — below-average profitability
  • Revenue growing at 8% annually

Envista Holdings Corporation Common Stock (NVST) is a Healthcare company operating in Dental Equipment & Supplies, listed on the NYSE , with a market capitalisation of $3.8 billion . Key value metrics: P/E ratio 72.2, P/B ratio 1.24, Piotroski F-Score 9 out of 9 (strong financial health) .

Value Score

Key Metrics

P/E Ratio
72.21
1.24
EPS
$0.32
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Envista Holdings Corporation Common Stock — Fundamental Analysis Summary

Envista Holdings Corporation Common Stock (NVST) is currently trading 99% above its Graham Number of $11.75, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 72.2x.

On financial health, NVST shows a strong Piotroski F-Score of 9/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 1.7% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.47.

StockPik's composite Value Score for NVST is 87/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

NVST reports a solid gross margin of 54.8% (sector average: 40.1%) and a modest operating margin of 7.7%.

NVST shows revenue growing at 8% year-over-year, with earnings growing at 104%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
EMBC $3.90 2.1 100
HCM $13.31 5.1 100
GMAB $27.06 1.8 100
CGEN $2.71 7.3 100
INVA $22.89 5.8 100
High Piotroski F-Score stocks
Other stocks with F-Score ≥ 7 showing broad financial improvement
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
NVS
Next
NVT